This Techtalk will focus on Genome editing.
Six speakers with different background will address applications of CRISPR-Cas technology in microbiology and haematology therapy and in agriculture. Also, the transition of Cripr-cas technology from fundamental research to commerce and the risks of gene drives will be discussed.

During the Q&A we invite everyone to participate and share your insights on the challenges, advantages and roles of genome editing in the near future.

Sign up if you haven't already.